A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Sirukumab in the Treatment of Giant Cell Arteritis
posted on 2020-08-17, 14:45authored byWolfgang A. Schmidt, Bhaskar Dasgupta, Raashid Luqmani, Sebastian H. Unizony, Daniel Blockmans, Zhihong Lai, Regina H. Kurrasch, Ivana Lazic, Ravi Rao
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).